Inventor · disambiguated record
Janos Tibor Kodra
Also filed as: KODRA JANOS T · KODRA JANOS TIBOR · KODRA JÁNOS TIBOR
33 granted patents·17 pending applications·811 citations·filing 2000–2020
98Inventor score
Top patents by PatentIndex Score
50 records- 0198US7812043B2N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetesTRANSTECH PHARMA INC·Filed 2006·Granted Oct 12, 2010·93 cites·11 claims
- 0298US7541373B2Aryl carbonyl derivatives as therapeutic agentsNOVO NORDISK AS·Filed 2006·Granted Jun 2, 2009·123 cites·22 claims
- 0398US7384967B2Aryl carbonyl derivatives as therapeutic agentsNOVO NORDISK AS·Filed 2003·Granted Jun 10, 2008·166 cites·108 claims
- 0496USRE45670EAryl carbonyl derivatives as therapeutic agentsNOVO NORDISK AS·Filed 2013·Granted Sep 15, 2015·34 cites·22 claims
- 0595US6875760B2Glucagon antagonists/inverse agonistsNOVO NORDISK AS·Filed 2002·Granted Apr 5, 2005·56 cites·80 claims
- 0694US8067362B2Insulin derivativesKODRA JANOS TIBOR·Filed 2006·Granted Nov 29, 2011·27 cites·6 claims
- 0794US6953812B2Glucagon antagonists/inverse agonistsNOVO NORDISK INC·Filed 2003·Granted Oct 11, 2005·56 cites·54 claims
- 0893US6762318B2Glucagon antagonistsNOVO NORDISK AS·Filed 2002·Granted Jul 13, 2004·54 cites·59 claims
- 0992US8691759B2Protease stabilized, acylated insulin analoguesMADSEN PETER·Filed 2009·Granted Apr 8, 2014·15 cites·14 claims
- 1092US6562807B2Glucagon antagonists/inverse agonistsNOVO NORDISK AS·Filed 2001·Granted May 13, 2003·28 cites·70 claims
- 1191US7897628B2Aryl carbonyl derivatives as therapeutic agentsNOVO NORDISK AS·Filed 2007·Granted Mar 1, 2011·15 cites·22 claims
- 1291US6881746B2Glucagon antagonists/inverse agonistsNOVO NORDISK AS·Filed 2003·Granted Apr 19, 2005·35 cites·32 claims
- 1389US9688737B2Protease stabilized acylated insulin analoguesNOVO NORDISK AS·Filed 2015·Granted Jun 27, 2017·6 cites·12 claims
- 1488US8962794B2Insulins with an acyl moiety comprising repeating units of alkylene glycol containing amino acidsMADSEN PETER·Filed 2008·Granted Feb 24, 2015·8 cites·4 claims
- 1588US8933021B2Insulin derivativeHUBALEK FRANTISEK·Filed 2007·Granted Jan 13, 2015·8 cites·14 claims
- 1687US10689429B2Double-acylated GLP-1 compoundsNOVO NORDISK AS·Filed 2015·Granted Jun 23, 2020·7 cites·11 claims
- 1787US8476228B2Insulin derivativesKODRA JANOS TIBOR·Filed 2011·Granted Jul 2, 2013·6 cites·9 claims
- 1886US9708383B2Double-acylated GLP-1 derivativesMADSEN ALICE RAVN·Filed 2011·Granted Jul 18, 2017·14 cites·16 claims
- 1985US6927214B1Non-peptide GLP-1 agonistsNOVO NORDISK AS·Filed 2000·Granted Aug 9, 2005·17 cites·27 claims
- 2084US8796205B2Insulin derivativeJONASSEN IB·Filed 2007·Granted Aug 5, 2014·6 cites·11 claims
- 2184US8722620B2Insulin derivativesFYNBO CHARLOTTE HARKJAER·Filed 2007·Granted May 13, 2014·11 cites·29 claims
- 2283US8148413B2N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetesLAU JESPER·Filed 2010·Granted Apr 3, 2012·3 cites·8 claims
- 2383US8063081B2Aryl carbonyl derivatives as therapeutic agentsPOLISETTI DHARMA RAO·Filed 2007·Granted Nov 22, 2011·6 cites·17 claims
- 2477US10946074B2GLP-1 derivatives and uses thereofNOVO NORDISK AS·Filed 2017·Granted Mar 16, 2021·2 cites·15 claims
- 2576US9150633B2Insulin analogues with an acyl and alkylene glycol moietyMADSEN PETER·Filed 2008·Granted Oct 6, 2015·3 cites·4 claims
- 2675US9657079B2Truncated GLP-1 derivatives and their therapeutical useNOVO NORDISK AS·Filed 2014·Granted May 23, 2017·2 cites·14 claims
- 2774US10822385B2EGF(A) analogues with fatty acid substituentsNOVO NORDISK AS·Filed 2017·Granted Nov 3, 2020·1 cites·28 claims
- 2874US8835379B2Derivatives of CGRPNIELSEN ANETTE SAMS·Filed 2010·Granted Sep 16, 2014·6 cites·11 claims
- 2972US10259856B2Protease stabilized acylated insulin analoguesNOVO NORDISK AS·Filed 2015·Granted Apr 16, 2019·1 cites·18 claims
- 3068US2009240028A1Synthesis and Application of New Structural Well Defined Branched Polymers as Conjugating Agents for PeptidesNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 3166USRE46170EInsulin derivativesNOVO NORDISK AS·Filed 2014·Granted Oct 4, 2016·0 cites·9 claims
- 3265US9040660B2Long-acting gastrin derivativesKOFOED JACOB·Filed 2011·Granted May 26, 2015·2 cites·3 claims
- 3363US2019112348A1Protease stabilized, acylated insulin analoguesNOVO NORDISK AS·Filed 2018·Application pending·0 cites
- 3460US2009143592A1Glucagon Antagonists/Inverse AgonistsNOVO NORDISK AS·Filed 2007·Application pending·0 cites
- 3560US2006182714A1Synthesis and application of new structural well defined branched polymers as conjugating agents for peptidesNOVO NORDISK AS·Filed 2006·Application pending·0 cites
- 3658US2005256175A1Novel glucagon antagonists/inverse agonistsLAU JESPER·Filed 2005·Application pending·0 cites
- 3758US2010292133A1Truncated glp-1 derivaties and their therapeutical useNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 3857US2020407409A1Egf(a) analogues with fatty acid substituentsCHEN JIANHE·Filed 2020·Application pending·0 cites
- 3954US2005203108A1Glucagon antagonists/inverse agonistsFiled 2004·Application pending·0 cites
- 4054US2011301158A1Aryl carbonyl derivatives as therapeutic agentsPOLISETTI DHARMA RAO·Filed 2011·Application pending·0 cites
- 4153US9035020B1Insulins with an acyl moiety comprising repeating units of alkylene glycol containing amino acidsNOVO NORDISK AS·Filed 2015·Granted May 19, 2015·0 cites·1 claims
- 4253US2009036353A1Insulin Derivatives Conjugated with Structurally Well Defined Branched PolymersNOVO NORDISK AS·Filed 2006·Application pending·0 cites
- 4352US2010029903A1Polypeptide Protracting TagsNOVO NORDISK AS·Filed 2006·Application pending·0 cites
- 4448US2007015757A1Novel Glucagon Antagonists/Inverse AgonistsNOVO NORDISK AS·Filed 2006·Application pending·0 cites
- 4543US2004152750A1Novel glucagon antagonistsFiled 2003·Application pending·0 cites
- 4643US2003171411A1Amide derivatives as therapeutic agentsFiled 2002·Application pending·0 cites
- 4743US2006105948A1GLP-2 derivativesNOVO NORDISK AS·Filed 2005·Application pending·0 cites
- 4841US11471537B2Oligomer extended insulin-Fc conjugatesNOVO NORDISK AS·Filed 2018·Granted Oct 18, 2022·0 cites·19 claims
- 4940US2015344540A1Novel glp-1 receptor agonists with cholesterol efflux activityNOVO NORDISK AS·Filed 2013·Application pending·0 cites
- 5033US2014018290A1Leptin derivativesKODRA JANOS TIBOR·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →